{
    "cancer_type": "Myeloproliferative Neoplasms",
    "title": "Myeloproliferative Neoplasmsâ€”Patient Version",
    "url": "https://www.cancer.gov/types/myeloproliferative",
    "content": [
        {
            "section": "Paragraph",
            "text": "Myeloproliferative neoplasms and myelodysplastic syndromes are diseases of the blood cells and bone marrow. Sometimes both conditions are present. Explore the links on this page to learn about their treatment, research, and clinical trials."
        },
        {
            "section": "Paragraph",
            "text": "The information in this section is meant to help you cope with the many issues and concerns that occur when you have cancer."
        },
        {
            "section": "Paragraph",
            "text": "National Cancer Institute\nat the National Institutes of Health"
        }
    ],
    "related_links": [
        "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms"
    ],
    "related_pages": {
        "Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes": {
            "cancer_type": "Myeloproliferative Neoplasms",
            "title": "Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes",
            "url": "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms",
            "content": [
                {
                    "section": "Paragraph",
                    "text": "This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms or myelodysplastic syndromes. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative neoplasms or myelodysplastic syndromes. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used."
                },
                {
                    "section": "Paragraph",
                    "text": "The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in myeloproliferative neoplasms or myelodysplastic syndromes that are not listed here."
                },
                {
                    "section": "Paragraph",
                    "text": "National Cancer Institute\nat the National Institutes of Health"
                }
            ],
            "related_links": [
                "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms#main-content",
                "mailto:?subject=Information%20from%20the%20National%20Cancer%20Institute%20Web%20Site%20&body=I%20found%20this%20information%20on%20www.cancer.gov%20and%20I%27d%20like%20to%20share%20it%20with%20you:%20https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms%20%0D%0A%0D%0A%20NCI%27s%20Web%20site,%20www.cancer.gov,%20provides%20accurate,%20up-to-date,%20comprehensive%20cancer%20information%20from%20the%20U.S.%20government%27s%20principal%20agency%20for%20cancer%20research.%20If%20you%20have%20questions%20or%20need%20additional%20information,%20we%20invite%20you%20to%20contact%20NCI%27s%20LiveHelp%20instant%20messaging%20service%20at%20https://livehelp.cancer.gov,%20or%20call%20the%20NCI%27s%20Contact%20Center%201-800-4-CANCER%20(1-800-422-6237)%20(toll-free%20from%20the%20United%20States).",
                "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms#1",
                "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms#2",
                "mailto:?subject=Information%20from%20the%20National%20Cancer%20Institute%20Web%20Site%20&body=I%20found%20this%20information%20on%20www.cancer.gov%20and%20I%27d%20like%20to%20share%20it%20with%20you:%20https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms%20%0D%0A%0D%0A%20NCI%27s%20Web%20site,%20www.cancer.gov,%20provides%20accurate,%20up-to-date,%20comprehensive%20cancer%20information%20from%20the%20U.S.%20government%27s%20principal%20agency%20for%20cancer%20research.%20If%20you%20have%20questions%20or%20need%20additional%20information,%20we%20invite%20you%20to%20contact%20NCI%27s%20LiveHelp%20instant%20messaging%20service%20at%20https://livehelp.cancer.gov,%20or%20call%20the%20NCI%27s%20Contact%20Center%201-800-4-CANCER%20(1-800-422-6237)%20(toll-free%20from%20the%20United%20States)."
            ],
            "related_pages": {
                "Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes": {
                    "cancer_type": "Myeloproliferative Neoplasms",
                    "title": "Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes",
                    "url": "mailto:?subject=Information%20from%20the%20National%20Cancer%20Institute%20Web%20Site%20&body=I%20found%20this%20information%20on%20www.cancer.gov%20and%20I%27d%20like%20to%20share%20it%20with%20you:%20https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms%20%0D%0A%0D%0A%20NCI%27s%20Web%20site,%20www.cancer.gov,%20provides%20accurate,%20up-to-date,%20comprehensive%20cancer%20information%20from%20the%20U.S.%20government%27s%20principal%20agency%20for%20cancer%20research.%20If%20you%20have%20questions%20or%20need%20additional%20information,%20we%20invite%20you%20to%20contact%20NCI%27s%20LiveHelp%20instant%20messaging%20service%20at%20https://livehelp.cancer.gov,%20or%20call%20the%20NCI%27s%20Contact%20Center%201-800-4-CANCER%20(1-800-422-6237)%20(toll-free%20from%20the%20United%20States).",
                    "content": [
                        {
                            "section": "Paragraph",
                            "text": "This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms or myelodysplastic syndromes. The list includes generic and brand names. This page also lists common drug combinations used in myeloproliferative neoplasms or myelodysplastic syndromes. The individual drugs in the combinations are FDA-approved. However, drug combinations themselves usually are not approved, but are widely used."
                        },
                        {
                            "section": "Paragraph",
                            "text": "The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in myeloproliferative neoplasms or myelodysplastic syndromes that are not listed here."
                        },
                        {
                            "section": "Paragraph",
                            "text": "National Cancer Institute\nat the National Institutes of Health"
                        }
                    ],
                    "related_links": [
                        "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms#main-content",
                        "mailto:?subject=Information%20from%20the%20National%20Cancer%20Institute%20Web%20Site%20&body=I%20found%20this%20information%20on%20www.cancer.gov%20and%20I%27d%20like%20to%20share%20it%20with%20you:%20https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms%20%0D%0A%0D%0A%20NCI%27s%20Web%20site,%20www.cancer.gov,%20provides%20accurate,%20up-to-date,%20comprehensive%20cancer%20information%20from%20the%20U.S.%20government%27s%20principal%20agency%20for%20cancer%20research.%20If%20you%20have%20questions%20or%20need%20additional%20information,%20we%20invite%20you%20to%20contact%20NCI%27s%20LiveHelp%20instant%20messaging%20service%20at%20https://livehelp.cancer.gov,%20or%20call%20the%20NCI%27s%20Contact%20Center%201-800-4-CANCER%20(1-800-422-6237)%20(toll-free%20from%20the%20United%20States).",
                        "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms#1",
                        "https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms#2",
                        "mailto:?subject=Information%20from%20the%20National%20Cancer%20Institute%20Web%20Site%20&body=I%20found%20this%20information%20on%20www.cancer.gov%20and%20I%27d%20like%20to%20share%20it%20with%20you:%20https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms%20%0D%0A%0D%0A%20NCI%27s%20Web%20site,%20www.cancer.gov,%20provides%20accurate,%20up-to-date,%20comprehensive%20cancer%20information%20from%20the%20U.S.%20government%27s%20principal%20agency%20for%20cancer%20research.%20If%20you%20have%20questions%20or%20need%20additional%20information,%20we%20invite%20you%20to%20contact%20NCI%27s%20LiveHelp%20instant%20messaging%20service%20at%20https://livehelp.cancer.gov,%20or%20call%20the%20NCI%27s%20Contact%20Center%201-800-4-CANCER%20(1-800-422-6237)%20(toll-free%20from%20the%20United%20States)."
                    ],
                    "related_pages": {}
                }
            }
        }
    }
}